SCHEMBL4015880

SCHEMBL4015880

CCn1nc(OC)c(-c2ccccc2)c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.47
GAA P10253 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ILK Q13418 1/20 0.42
MAPT P10636 6/20 0.41
RAB9A P51151 5/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
HPGD P15428 3/20 0.40
CASP1 P29466 1/20 0.40
NR1H3 Q13133 1/20 0.38
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13974933 0.79 MAPT (0.62) POLBGAACYP1A2CYP3A4CYP2D6
SCHEMBL692697 0.72 ILK (0.30) ILK
SCHEMBL29041058 0.70 MEN1 (0.50) POLBGAACYP1A2ILKMAPT
SCHEMBL4164612 0.69 POLB (0.46) POLBGAAILKMAPTRAB9A
SCHEMBL13860530 0.69 MAPT (0.57) POLBGAAMAPTRAB9AMEN1
SCHEMBL16200220 0.68 MAPK1 (0.48) POLBGAACYP1A2ILKMAPT
SCHEMBL16200211 0.68 MEN1 (0.48) POLBGAACYP1A2CYP3A4CYP2D6
SCHEMBL1270330 0.67 NPC1 (0.51) POLBMAPTRAB9AMEN1KMT2A
SCHEMBL1075673 0.67 CYP1A2 (0.53) POLBGAACYP1A2CYP3A4CYP2D6
SCHEMBL4163853 0.66 POLB (0.41) POLBGAAILKMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044063-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008001070-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-01-03 WO disclosed